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Case
Rheumatoid nodules (RN) are not only unsightly and
functionally limiting but also indicate poor prognosis in
rheumatoid arthritis (RA) [1]. Treatment options are
limited as traditional disease modifying antirheumatic
drugs (DMARDs) like Methotrexate [2], Cyclosporine
[3], Leflunomide [4] and anti TNF therapy [5,6] can
make RN worse. RN can also recur after intranodular
steroid injections [7] or surgical excision [8].
We report the case of a forty three year old man who
was diagnosed with RA at the age of 26 years however was
started on sequential DMARDS only four years later upon
referral to Rheumatology, by which time RN had devel-
oped on his elbows. He was found to have seropositive,
erosive RA and was started on Sulfasalazine, and a few
months later oral Methotrexate and Hydroxychloroquine
were added sequentially. Despite these measures, his
arthritis was sub-optimally controlled and his RN contin-
ued to deteriorate.
In November 2009 he was diagnosed with head and
neck squamous cell carcinoma involving his neck, nasal
cavity and tongue. All DMARDs were discontinued on
diagnosis. He received a six week course of Cisplatin as a
single chemotherapeutic agent in Jan/Feb ’10 in addition
to local radiotherapy.
He noticed that his RN started to disappear during che-
motherapy. His arthritis has been in complete remission
after his course of cisplatin and has not noticed any recur-
rence of RN despite remaining off all DMARDs till
November 2011.
Discussion
Our patient had sustained remission of RA and complete
disappearance of RN with Cisplatin which has not been
achieved with other treatment modalities e.g, Tacrolimus
[9] and Colchicine [10]. Although D-penicillamine has
shown to be effective in treatment of RN [11,12]it is not
very effective in controlling RA, hence the need for
further studies of Cisplatin in the management of RA
and RN.
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